ALL patients & allo-HSCT VJHemOnc – Video Journal of Hematology & HemOnc 3:03 3 years ago 152 Скачать Далее
Allo-HSCT for CLL in the era of novel agents VJHemOnc – Video Journal of Hematology & HemOnc 2:37 4 years ago 115 Скачать Далее
Allo-HSCT and CAR T-cell: looking to EBMT 2020 VJHemOnc – Video Journal of Hematology & HemOnc 1:10 4 years ago 115 Скачать Далее
Optimal time for allo-HSCT in AML VJHemOnc – Video Journal of Hematology & HemOnc 0:38 3 years ago 90 Скачать Далее
Novel scoring system defines allo-HSCT patients at high risk for CMV VJHemOnc – Video Journal of Hematology & HemOnc 6:45 3 years ago 133 Скачать Далее
CD4+ T-cell reconstitution in allo-HSCT settings VJHemOnc – Video Journal of Hematology & HemOnc 3:40 3 years ago 59 Скачать Далее
Reduced-intensity conditioning regimens in ALL patients undergoing allo-HSCT VJHemOnc – Video Journal of Hematology & HemOnc 6:59 4 years ago 309 Скачать Далее
REACT: ELISPOT assay predicts CMV reactivation in allo-HSCT patients VJHemOnc – Video Journal of Hematology & HemOnc 1:22 3 years ago 127 Скачать Далее
Mutational profiles of MDS patients undergoing allo-HSCT VJHemOnc – Video Journal of Hematology & HemOnc 1:29 3 years ago 42 Скачать Далее
Impact of post-transplant TKIs on long-term outcomes of allo-HSCT in ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:27 3 years ago 47 Скачать Далее
αβ T-cell depleted allo-HSCT for hematological malignancies VJHemOnc – Video Journal of Hematology & HemOnc 1:16 3 years ago 84 Скачать Далее
Outcomes after allo-HSCT for Diamond-Blackfan anemia VJHemOnc – Video Journal of Hematology & HemOnc 2:14 3 years ago 175 Скачать Далее
R/R DLBCL: impact of allo-HSCT conditioning on patient survival VJHemOnc – Video Journal of Hematology & HemOnc 4:00 4 years ago 53 Скачать Далее
Improved survival of myelofibrosis patients receiving ruxolitinib post allo-HSCT VJHemOnc – Video Journal of Hematology & HemOnc 2:14 3 years ago 284 Скачать Далее
GvHD prophylaxis: PTCY vs ATG in AML with allo-HSCT VJHemOnc – Video Journal of Hematology & HemOnc 3:13 4 years ago 331 Скачать Далее
The role of allo-HSCT in treating relapsed patients with multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:43 2 years ago 77 Скачать Далее
Survival trends for patients with relapsed Ph+ ALL after allo-HSCT VJHemOnc – Video Journal of Hematology & HemOnc 3:26 3 years ago 224 Скачать Далее
Dynamic assessment of peripheral perfusion in allo-HSCT survivors VJHemOnc – Video Journal of Hematology & HemOnc 4:09 3 years ago 53 Скачать Далее
Allo-HSCT and novel drugs for refractory AML VJHemOnc – Video Journal of Hematology & HemOnc 2:26 3 years ago 78 Скачать Далее
Predictors for autoimmune cytopenias in pediatric allo-HSCT VJHemOnc – Video Journal of Hematology & HemOnc 3:35 3 years ago 75 Скачать Далее
